carbostyril and HIV
carbostyril has been researched along with HIV in 27 studies
Research
Studies (27)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.70) | 18.2507 |
2000's | 8 (29.63) | 29.6817 |
2010's | 17 (62.96) | 24.3611 |
2020's | 1 (3.70) | 2.80 |
Authors
Authors | Studies |
---|---|
Ma, R; Tong, ZW; Xu, B; Zhang, Q; Zhang, YS; Zhao, CS; Zhao, RG | 1 |
Clark, MR; Deng, Y; Mohideen, M; Panse, G; Quijano, E; Saltzman, WM; Song, E; Zhang, W | 1 |
Chauhan, M; Chokkar, N; Kalra, S; Kumar, R | 1 |
Cassetti, I; Castillo, S; Cecchini, DM; Copertari, G; Lacal, V; Rodriguez, CG | 1 |
Ambrosioni, J; de Lazzari, E; García, F; Marcos, MÁ; Miró, JM; Mosquera, MM; Nicolás, D; Rico, JÁF | 1 |
Ayala-Sims, VA; Fulco, PP | 1 |
Debyser, Z; Schrijvers, R | 1 |
Arribas, JR; Di Perri, G; Ebrahimi, R; Gathe, J; Nguyen, T; Pialoux, G; Piontkowsky, D; Reynes, J; Tebas, P; White, K | 1 |
Antela, A; Domingo, P; Garner, W; Girard, PM; Guyer, B; Henry, K; Markowitz, M; Mills, A; Nguyen, T; Piontkowsky, D; Pozniak, A; Stellbrink, HJ; White, K | 1 |
Barreca, ML; Cecchetti, V; Corazza, G; Daelemans, D; Iraci, N; Manfroni, G; Marcello, A; Massari, S; Pannecouque, C; Sancineto, L; Tabarrini, O | 1 |
Grobler, JA; Hazuda, DJ | 1 |
Castagna, A; Chiappetta, S; Galli, L; Lazzarin, A; Nozza, S; Poli, A; Ripa, M; Rovelli, C; Spagnuolo, V; Tambussi, G | 1 |
Chen, FE; Chen, WX; Daelemans, D; De Clercq, E; He, QQ; Mao, TQ; Pannecouque, C; Tang, GF | 1 |
Hazuda, D; Iwamoto, M; Wenning, L | 1 |
Grant, P; Zolopa, A | 1 |
Cecchetti, V; Daelemans, D; Manfroni, G; Massari, S; Pannecouque, C; Sabatini, S; Tabarrini, O | 1 |
Christ, F; Debyser, Z; McNeely, M; Thys, W | 1 |
de Mendoza, C; Garrido, C; Soriano, V | 1 |
Cardona, C; Cauvin, C; Georges, B; Guiguen, A; Hevesi, L; Le Van, K; Mbemba, G; Michaux, C; Mouscadet, JF; Van Lint, C; Vandurm, P; Wouters, J | 1 |
Cecchetti, V; Ianni, F; Massari, S; Natalini, B; Sardella, R; Tabarrini, O | 1 |
Breeze, S | 1 |
Hutadilok-Towatana, N; Panthong, K; Rukachaisirikul, V; Srisud, Y; Tewtrakul, S; Voravuthikunchai, SP | 1 |
Bastow, KF; Chen, Y; Lee, KH; Morris-Natschke, SL; Xia, P; Xia, Y; Yang, ZY; Zhang, Q; Zheng, YQ | 1 |
Maurin, MB; Xie, M; Ziemba, TM | 1 |
Bringmann, G; Cai, P; Feineis, D; Heguy, A; Houck, D; Katz, B; Meyn, P; Michitsch, R; Pearce, C; Russo, S; Taylor, DL; Tyms, AS | 1 |
Cecchetti, V; Cruciani, G; Filipponi, E; Fravolini, A; Tabarrini, O | 1 |
Reviews
6 review(s) available for carbostyril and HIV
Article | Year |
---|---|
A Review on Quinoline Derived Scaffolds as Anti-HIV Agents.
Topics: Animals; Anti-HIV Agents; Drug Discovery; HIV; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; Humans; Models, Molecular; Quinolones | 2019 |
Resistance to HIV integrase strand transfer inhibitors: in vitro findings and clinical consequences.
Topics: Drug Resistance, Viral; Heterocyclic Compounds, 3-Ring; HIV; HIV Integrase; HIV Integrase Inhibitors; Humans; Mutation, Missense; Oxazines; Piperazines; Pyridones; Pyrrolidinones; Quinolones; Raltegravir Potassium; Virulence; Virus Replication | 2014 |
Emerging pharmacology: inhibitors of human immunodeficiency virus integration.
Topics: Animals; HIV; HIV Integrase Inhibitors; Humans; Models, Theoretical; Molecular Structure; Pharmacology, Clinical; Pyrrolidinones; Quinolones; Raltegravir Potassium; Virus Integration | 2009 |
Integrase inhibitors: a clinical review of raltegravir and elvitegravir.
Topics: Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; HIV; HIV Infections; HIV Integrase; HIV Protease Inhibitors; Humans; Pyrrolidinones; Quinolones; Raltegravir Potassium | 2008 |
Targeting the HIV integration process in antiviral therapy.
Topics: HIV; HIV Infections; HIV Integrase Inhibitors; Humans; Pyrrolidinones; Quinolones; Raltegravir Potassium; Virus Integration | 2008 |
[Resistance to integrase inhibitors].
Topics: Amino Acid Substitution; Clinical Trials as Topic; Drug Resistance, Multiple, Viral; Drug Resistance, Viral; Genetic Variation; HIV; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; Humans; Models, Molecular; Mutation, Missense; Point Mutation; Protein Conformation; Pyrrolidinones; Quinolones; Raltegravir Potassium | 2008 |
Trials
2 trial(s) available for carbostyril and HIV
Article | Year |
---|---|
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results o
Topics: Adenine; Adult; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Protease Inhibitors; Quinolones; Ritonavir; Tenofovir; Thiazoles; Viral Load | 2014 |
Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week r
Topics: Adenine; Adult; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Emtricitabine; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Quinolones; Reverse Transcriptase Inhibitors; Tenofovir; Thiazoles; Viral Load | 2014 |
Other Studies
19 other study(ies) available for carbostyril and HIV
Article | Year |
---|---|
Preoperative rapid suppression of viral load by elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide regimen in human immunodeficiency virus-positive fracture patients significantly reduces postoperative complications.
Topics: Adenine; Alanine; Anti-HIV Agents; Cobicistat; Drug Combinations; Emtricitabine; HIV; HIV Infections; Humans; Postoperative Complications; Quinolones; Tenofovir; Viral Load | 2020 |
Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Delayed-Action Preparations; Female; HIV; HIV Infections; Humans; Mice, Inbred C57BL; Nanoparticles; Quinolones; Vagina | 2017 |
Resistance to HIV integrase strand transfer inhibitors in Argentina: first interim survey.
Topics: Adult; Argentina; Drug Resistance, Viral; Female; Heterocyclic Compounds, 3-Ring; HIV; HIV Infections; HIV Integrase Inhibitors; Humans; Male; Middle Aged; Oxazines; Pilot Projects; Piperazines; Prevalence; Pyridones; Quinolones; Raltegravir Potassium; Retrospective Studies; Surveys and Questionnaires; Urban Population; Viral Load; Young Adult | 2019 |
E157Q integrase strand-transfer inhibitor substitution in patients with acute/recent HIV infection.
Topics: Adult; Amino Acid Substitution; Disease Transmission, Infectious; Drug Resistance, Viral; Female; Gene Frequency; Genotype; Genotyping Techniques; High-Throughput Nucleotide Sequencing; HIV; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; Humans; Male; Molecular Epidemiology; Mutation, Missense; Phylogeny; Prevalence; Prospective Studies; Quinolones; Raltegravir Potassium; Sexual and Gender Minorities; Viral Load | 2019 |
Sustained virological response after taking crushed elvitegravir-cobicistat-emtricitabine-tenofovir tablets.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Carbamates; Cobicistat; Deoxycytidine; Emtricitabine; Female; HIV; HIV Infections; Humans; Organophosphonates; Powders; Quinolones; Tablets; Tenofovir; Thiazoles; Viral Load | 2014 |
Switching STRATEGIES in HIV treatment.
Topics: Adenine; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Emtricitabine; Female; HIV; HIV Infections; Humans; Male; Organophosphonates; Protease Inhibitors; Quinolones; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Thiazoles | 2014 |
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands.
Topics: Anti-HIV Agents; Cell Line; Dose-Response Relationship, Drug; HIV; Humans; Ligands; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quinolones; Structure-Activity Relationship; Virus Replication | 2014 |
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cobicistat; Emtricitabine; HIV; HIV Infections; Humans; Male; Middle Aged; Quinolones; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load | 2017 |
Structural Modifications of Diarylpyrimidine-quinolone Hybrids as Potent HIV-1 NNRTIs with an Improved Drug Resistance Profile.
Topics: Anti-HIV Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Viral; HIV; HIV Reverse Transcriptase; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrimidines; Quinolones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication | 2016 |
Studies on anti-HIV quinolones: new insights on the C-6 position.
Topics: Anti-HIV Agents; HIV; Humans; Quinolones; Structure-Activity Relationship; Transcription, Genetic; Virus Replication | 2009 |
Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
Topics: Anti-HIV Agents; Catalytic Domain; Dose-Response Relationship, Drug; Drug Design; HIV; HIV Integrase; HIV Integrase Inhibitors; Keto Acids; Models, Molecular; Molecular Structure; Quinolones; Stereoisomerism; Structure-Activity Relationship | 2011 |
Synthesis and chromatographic enantioresolution of anti-HIV quinolone derivatives.
Topics: Acetic Acid; Amylose; Anti-HIV Agents; Cellulose; Chloroform; Chromatography, High Pressure Liquid; Ethanol; HIV; Humans; Mesylates; Methanol; Models, Chemical; Molecular Structure; Phenylcarbamates; Quinolones; Stereoisomerism; Trifluoroacetic Acid | 2011 |
A 4-drug combination (Stribild) for HIV.
Topics: Adenine; Anti-HIV Agents; Carbamates; Clinical Trials as Topic; Cobicistat; Deoxycytidine; Double-Blind Method; Drug Approval; Drug Combinations; Drug Interactions; Drug Resistance, Multiple, Viral; Emtricitabine; HIV; HIV Infections; Humans; Organophosphonates; Quinolones; Randomized Controlled Trials as Topic; Tenofovir; Thiazoles; United States; United States Food and Drug Administration | 2012 |
Novel HIV-1 treatment Stribild™ gains regulatory approval.
Topics: Adenine; Anti-HIV Agents; Carbamates; Deoxycytidine; Drug Approval; Drug Combinations; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV; HIV Infections; Humans; Organophosphonates; Quinolones; Thiazoles | 2012 |
Benzene, coumarin and quinolinone derivatives from roots of Citrus hystrix.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Antioxidants; Bacteria; Benzene; Cells, Cultured; Citrus; Coumarins; HIV; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Plant Roots; Quinolones | 2013 |
Synthesis and bioactivity of 4,10-dimethyl-pyridino[2,3-h]quinolin-2(1H)-one-9-carboxylic acid and its esters.
Topics: Anti-HIV Agents; Antineoplastic Agents; Cell Survival; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; HIV; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Quinolones; Tumor Cells, Cultured | 2003 |
Sublimation characterization and vapor pressure estimation of an HIV nonnucleoside reverse transcriptase inhibitor using thermogravimetric analysis.
Topics: Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; HIV; Quinolones; Reverse Transcriptase Inhibitors; Technology, Pharmaceutical; Thermodynamics; Thermogravimetry; Volatilization | 2003 |
Isolation and characterization of the fungal metabolite 3-O-methylviridicatin as an inhibitor of tumour necrosis factor alpha-induced human immunodeficiency virus replication.
Topics: Anti-HIV Agents; Fungi; HeLa Cells; HIV; HIV Long Terminal Repeat; Humans; Hydroxyquinolines; Microbial Sensitivity Tests; Quinolones; Tumor Necrosis Factor-alpha; Virus Replication | 1998 |
QSAR study and VolSurf characterization of anti-HIV quinolone library.
Topics: Anti-HIV Agents; Computer-Aided Design; Databases, Factual; Drug Design; HIV; HIV Infections; Humans; Models, Chemical; Multivariate Analysis; Quantitative Structure-Activity Relationship; Quinolones; Software | 2001 |